Welcome to our dedicated page for Hercules Capital SEC filings (Ticker: HTGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hercules Capital, Inc. filings document the regulatory reporting of a specialty finance company that provides senior secured venture growth loans to technology and life sciences businesses. Its Form 8-K filings cover earnings releases, operating and financial condition updates, cash distribution declarations, executive leadership changes and related exhibits.
Proxy materials describe annual meeting matters, board governance, executive compensation and equity-award disclosures. The company’s filings also identify its NYSE-listed common stock under HTGC and its 6.25% Notes due 2033 under HCXY, tying capital-structure disclosures to both equity and debt securities.
Hercules Capital, Inc. director Thomas J. Fallon reported an indirect open-market purchase of 10,000 shares of common stock at $14.98 per share on February 24, 2026. The shares are held by the Fallon Family Revocable Trust.
After this transaction, the trust holds a total of 130,369 common shares, and Fallon also reports 5,779 common shares held directly. The filing highlights increased indirect ownership through the family trust structure.
Hercules Capital, Inc. director Thomas J. Fallon reported an indirect open-market purchase of 10,000 shares of common stock at $14.98 per share on February 24, 2026. The shares are held by the Fallon Family Revocable Trust.
After this transaction, the trust holds a total of 130,369 common shares, and Fallon also reports 5,779 common shares held directly. The filing highlights increased indirect ownership through the family trust structure.
Hercules Capital, Inc. director Gayle A. Crowell reported an open-market purchase of common stock. On February 23, 2026, Crowell bought 6,600 shares at a price of $15.20 per share. After this transaction, Crowell directly owned 87,458 shares of Hercules Capital common stock. The reported ownership total includes shares previously acquired through the company’s dividend reinvestment plan.
Hercules Capital, Inc. director Gayle A. Crowell reported an open-market purchase of common stock. On February 23, 2026, Crowell bought 6,600 shares at a price of $15.20 per share. After this transaction, Crowell directly owned 87,458 shares of Hercules Capital common stock. The reported ownership total includes shares previously acquired through the company’s dividend reinvestment plan.
Hercules Capital, Inc. Chief Executive Officer Scott Bluestein bought 30,000 shares of common stock in an open-market purchase. The shares were acquired at an average price of $15.08 each, with individual trade prices ranging from $15.04 to $15.10. Following this transaction, Bluestein directly owns 2,509,379 shares of Hercules Capital common stock.
Hercules Capital, Inc. Chief Executive Officer Scott Bluestein bought 30,000 shares of common stock in an open-market purchase. The shares were acquired at an average price of $15.08 each, with individual trade prices ranging from $15.04 to $15.10. Following this transaction, Bluestein directly owns 2,509,379 shares of Hercules Capital common stock.
Hercules Capital director Nikos Theodosopoulos bought 6,165 shares of common stock in an open-market purchase. The transaction took place on February 17, 2026, at an average price of $15.93 per share. Following this purchase, his directly owned stake increased to 18,923 shares.
Hercules Capital director Nikos Theodosopoulos bought 6,165 shares of common stock in an open-market purchase. The transaction took place on February 17, 2026, at an average price of $15.93 per share. Following this purchase, his directly owned stake increased to 18,923 shares.
Hercules Capital, Inc. director Thomas J. Fallon reported an indirect open-market purchase of 20,000 shares of Common Stock on February 17, 2026, at an average price of $15.88 per share. A footnote explains the price reflects purchases between $15.81 and $15.92.
The 20,000 shares are held by the Fallon Family Revocable Trust, bringing its indirect holdings to 120,369 shares. Separately, Fallon directly holds 5,779 shares, which reflects his personal stake outside the trust.
Hercules Capital, Inc. director Thomas J. Fallon reported an indirect open-market purchase of 20,000 shares of Common Stock on February 17, 2026, at an average price of $15.88 per share. A footnote explains the price reflects purchases between $15.81 and $15.92.
The 20,000 shares are held by the Fallon Family Revocable Trust, bringing its indirect holdings to 120,369 shares. Separately, Fallon directly holds 5,779 shares, which reflects his personal stake outside the trust.
Hercules Capital, Inc. reported record full-year 2025 results, with total investment income of $532.5 million, up 7.9% year-over-year, and net investment income of $341.7 million, or $1.91 per share, up 4.9%. Total gross debt and equity commitments reached $3.92 billion and gross fundings $2.28 billion.
In Q4 2025, total investment income was $137.4 million and net investment income was $87.0 million, or $0.48 per share, providing 120% coverage of the base cash distribution. Net asset value per share rose to $12.13 on 182.7 million shares.
The Board declared a fourth quarter 2025 total cash distribution of $0.47 per share, including a $0.40 base and $0.07 supplemental distribution, payable on March 4, 2026 to holders of record on February 25, 2026. A new supplemental cash distribution of $0.28 per share will be paid in four equal quarterly installments beginning with this quarter.
Hercules ended Q4 2025 with $525.5 million of available liquidity and a debt investment portfolio at fair value of $4.28 billion, 89.3% in first-lien senior secured loans and 97.9% floating rate. Loans on non-accrual fell to one position, representing 0.2% of the portfolio at cost. Subsequent to year-end, the company issued $300.0 million of 5.350% unsecured notes due 2029.
Hercules Capital, Inc. reported record full-year 2025 results, with total investment income of $532.5 million, up 7.9% year-over-year, and net investment income of $341.7 million, or $1.91 per share, up 4.9%. Total gross debt and equity commitments reached $3.92 billion and gross fundings $2.28 billion.
In Q4 2025, total investment income was $137.4 million and net investment income was $87.0 million, or $0.48 per share, providing 120% coverage of the base cash distribution. Net asset value per share rose to $12.13 on 182.7 million shares.
The Board declared a fourth quarter 2025 total cash distribution of $0.47 per share, including a $0.40 base and $0.07 supplemental distribution, payable on March 4, 2026 to holders of record on February 25, 2026. A new supplemental cash distribution of $0.28 per share will be paid in four equal quarterly installments beginning with this quarter.
Hercules ended Q4 2025 with $525.5 million of available liquidity and a debt investment portfolio at fair value of $4.28 billion, 89.3% in first-lien senior secured loans and 97.9% floating rate. Loans on non-accrual fell to one position, representing 0.2% of the portfolio at cost. Subsequent to year-end, the company issued $300.0 million of 5.350% unsecured notes due 2029.
HCXY’s filing outlines a large, highly diversified investment portfolio centered on senior secured debt, plus related equity and warrant positions. The portfolio spans application software, drug discovery and development, healthcare services, consumer and business services, sustainable technology, space technology, semiconductors and more.
Most debt investments are floating-rate loans tied to 1- or 3‑month SOFR, Prime, or SONIA with substantial credit spreads, floor rates, and frequent payment‑in‑kind (PIK) and exit fee features, and maturities generally running from 2025 into the early 2030s. HCXY also holds numerous preferred and common equity stakes, as well as warrants, in many of the same portfolio companies, and participates in investment funds and foreign currency contracts.
The text also highlights structural risks, including security interests on assets securing senior securities, potential volatility if preferred stock or convertible debt is issued, lack of an active trading market for certain notes, SBIC regulatory oversight of subsidiaries, and the possibility that capital market disruptions or tariff changes could negatively affect portfolio companies.
HCXY’s filing outlines a large, highly diversified investment portfolio centered on senior secured debt, plus related equity and warrant positions. The portfolio spans application software, drug discovery and development, healthcare services, consumer and business services, sustainable technology, space technology, semiconductors and more.
Most debt investments are floating-rate loans tied to 1- or 3‑month SOFR, Prime, or SONIA with substantial credit spreads, floor rates, and frequent payment‑in‑kind (PIK) and exit fee features, and maturities generally running from 2025 into the early 2030s. HCXY also holds numerous preferred and common equity stakes, as well as warrants, in many of the same portfolio companies, and participates in investment funds and foreign currency contracts.
The text also highlights structural risks, including security interests on assets securing senior securities, potential volatility if preferred stock or convertible debt is issued, lack of an active trading market for certain notes, SBIC regulatory oversight of subsidiaries, and the possibility that capital market disruptions or tariff changes could negatively affect portfolio companies.
Hercules Capital, Inc. has issued $300,000,000 in aggregate principal amount of its 5.350% Notes due 2029 under a Tenth Supplemental Indenture with U.S. Bank Trust Company, National Association. These unsecured notes pay 5.350% interest semiannually and mature on February 10, 2029, unless earlier redeemed.
The notes rank senior to expressly subordinated debt, equal with other unsubordinated liabilities, and are effectively and structurally subordinated to secured and subsidiary indebtedness. Hercules completed the transaction on February 10, 2026 and expects to use the net proceeds to fund investments, repay outstanding secured indebtedness and for other general corporate purposes.
Hercules Capital, Inc. has issued $300,000,000 in aggregate principal amount of its 5.350% Notes due 2029 under a Tenth Supplemental Indenture with U.S. Bank Trust Company, National Association. These unsecured notes pay 5.350% interest semiannually and mature on February 10, 2029, unless earlier redeemed.
The notes rank senior to expressly subordinated debt, equal with other unsubordinated liabilities, and are effectively and structurally subordinated to secured and subsidiary indebtedness. Hercules completed the transaction on February 10, 2026 and expects to use the net proceeds to fund investments, repay outstanding secured indebtedness and for other general corporate purposes.
Hercules Capital, Inc.'s Chief Financial Officer, Seth H. Meyer, reported share withholding transactions related to restricted stock vesting. On January 9, 2026, 15,965 shares of common stock were withheld at $18.59 per share to cover taxes due on vested restricted stock. On January 11, 2026, an additional 4,052 shares were withheld at $18.59 per share for the same purpose. Following these tax-withholding events, Meyer directly beneficially owned 434,553 shares of Hercules Capital common stock.
Hercules Capital, Inc.'s Chief Financial Officer, Seth H. Meyer, reported share withholding transactions related to restricted stock vesting. On January 9, 2026, 15,965 shares of common stock were withheld at $18.59 per share to cover taxes due on vested restricted stock. On January 11, 2026, an additional 4,052 shares were withheld at $18.59 per share for the same purpose. Following these tax-withholding events, Meyer directly beneficially owned 434,553 shares of Hercules Capital common stock.
Hercules Capital, Inc. reported insider equity activity by its Chief Operating Officer, Christian Follmann. The filing shows that on January 9, 2026, and January 11, 2026, a total of 7,580 and 1,178 shares of common stock, respectively, were withheld at a price of $18.59 per share to cover taxes due on vesting restricted stock awards. These are tax-withholding transactions coded as "F," not open-market sales. After these withholdings, Follmann directly beneficially owned 145,134 shares of common stock, and an additional 350 shares were held indirectly by his spouse.
Hercules Capital, Inc. reported insider equity activity by its Chief Operating Officer, Christian Follmann. The filing shows that on January 9, 2026, and January 11, 2026, a total of 7,580 and 1,178 shares of common stock, respectively, were withheld at a price of $18.59 per share to cover taxes due on vesting restricted stock awards. These are tax-withholding transactions coded as "F," not open-market sales. After these withholdings, Follmann directly beneficially owned 145,134 shares of common stock, and an additional 350 shares were held indirectly by his spouse.